Clinical Trial Update: Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes Phase 2 and Phase 3 studies evaluating dapagliflozin and saxagliptin for type 2 diabetes patients with controlled cancers, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Onglyza (Saxagliptin)

Snippet

Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING